MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can sweat and salad boost cancer treatment?
Disease control Recruiting nowThis study is testing whether adding high-intensity exercise and a high-fiber diet to standard immunotherapy can improve health outcomes for people with advanced melanoma. Researchers want to see if these lifestyle changes are doable during treatment and if they can improve gut h…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat skin cancer: experimental combo targets resistant melanoma
Disease control Recruiting nowThis study is testing whether adding a low-dose chemotherapy drug (cyclophosphamide) to an existing immunotherapy (pembrolizumab) can help patients with advanced melanoma that has stopped responding to standard treatments. The trial will enroll 14 adults with stage III or IV mela…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial offers hope for Tough-to-Treat advanced cancers
Disease control Recruiting nowThis is the first study in people to test a new drug called HMBD-501 for advanced cancers that have a specific marker called HER3 and have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can help shrink or control tumors in pa…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo targets deadly brain tumors from skin cancer
Disease control Recruiting nowThis study is testing whether a combination of two immunotherapy drugs, nivolumab and relatlimab, can help control melanoma that has spread to the brain. It will enroll about 30 adults with active brain metastases who have not received certain prior treatments. The main goals are…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Scientists hunt clues to why skin cancer fights back against treatment
Knowledge-focused Recruiting nowThis study aims to understand why some melanoma skin cancers become resistant to immunotherapy treatments. Researchers will analyze tumor samples from 20 patients with advanced melanoma before and after they receive immunotherapy. By studying how cancer cells' energy systems chan…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC